Basophilia predicts poorer outcomes in essential thrombocythemia, polycythemia vera, primary myelofibrosis, and myeloproliferative neoplasm, unclassifiable Research Letter

  

Authors:	Yuen, L.; Gogakos, T.; Boiocchi, L.; Hobbs, G.; Hasserjian, R.
Title:	Basophilia predicts poorer outcomes in essential thrombocythemia, polycythemia vera, primary myelofibrosis, and myeloproliferative neoplasm, unclassifiable
Keywords:	controlled study; myelofibrosis; major clinical study; overall survival; myeloid metaplasia; letter; phenotype; progression free survival; transforming growth factor beta; cohort analysis; chronic myeloid leukemia; retrospective study; hematopoietic cell; world health organization; drug therapy; myeloid progenitor cell; therapy; myeloproliferative neoplasm; polycythemia vera; thrombocythemia; acute myeloid leukemia; interleukin 3; human; basophilia
Journal Title:	American Journal of Hematology
Volume:	100
Issue:	2
ISSN:	0361-8609
Publisher:	John Wiley & Sons, Inc.
Date Published:	2025-02-01
Start Page:	320
End Page:	322
Language:	English
DOI:	10.1002/ajh.27530
PUBMED:	39578367
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85210023220&doi=10.1002%2fajh.27530&partnerID=40&md5=c7df1942dc4927a8734b8982126f27eb
Notes:	Letter -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/222301